Webinar: CDC Evaluation of a 2-Tier Lyme Disease EIA Testing Method and Potential Diagnostic Significance
This webinar will describe the potential diagnostic benefits of using the dissociated VIDAS® Lyme IgM II and VIDAS® Lyme IgG II assays in a 2-tier EIA approach vs. the use of the standard EIA/western blot algorithm. Register now!
Join bioMérieux for a robust educational evening with key opinion leaders to gain a better understanding of the integral role rapid results reporting plays in patient care decisions and Antimicrobial Stewardship initiatives in your hospital.
Professional Acknowledgment for Continuing Education® (P.A.C.E.®) credits will be offered.